CD24 and breast carcinoma: In addition, the distribution of circulating CD4 + CD25 + FOXP3+ Treg lymphocytes and CD19 + CD24 + CD38 + B lymphocytes significantly increased in breast cancer patients compared with healthy controls using blood samples [45].